Download this issue

EDITORIAL

• The evolving landscape of type 2 diabetes
  S. Colagiuri, Australia

THEMED ARTICLES

• • Sulfonylureas: historic to contemporary role in the management of type 2 diabetes
    D. R. Webb, M. Davies, K. Khunti , UK
  • Sulfonylureas in specific clinical situations: Ramadan
    S. Al Sifri, Kingdom of Saudi Arabia
  • Sulfonylureas in specific clinical situations: renal impairment
    S. Hadjadj, France
  • Sulfonylureas in specific clinical situations: elderly
    M. Yu, China
  • Sulfonylureas in specific clinical situations: maturity-onset diabetes of the young (MODY)
    J. Vassallo, Malta

CONTROVERSIAL QUESTION

• • • Sulfonylureas–should they stay or should they go?
      X. Cai, L. Ji , China – J. E. Costa Gil, Argentina – S. Dagdelen, Turkey – S. Sadikot, India – A. Zalevskaya, Russia

THERAPEUTIC OUTLOOK

• • Gliclazide MR as a standard of care in the management of type 2 diabetes
    A. Hohl, Brazil